Experimental Studies in Epilepsy: Immunologic and Inflammatory Mechanisms

Myers, 1974 Amor, 2010, Inflammation in neurodegenerative diseases, Immunology, 129, 154, 10.1111/j.1365-2567.2009.03225.x Aronica, 2012, Astrocyte immune responses in epilepsy, Glia, 60, 1258, 10.1002/glia.22312 Kramer, 2011, Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome: A multicenter study on 77 children, Epilepsia, 52, 1956, 10.1111/j.1528-1167.2011.03250.x McNaull, 2010, Inflammation and anti-inflammatory strategies for Alzheimer׳s disease—A mini-review, Gerontology, 56, 3, 10.1159/000237873 Schwartz, 2011, A conceptual revolution in the relationships between the brain and immunity, Brain Behav Immun, 25, 817, 10.1016/j.bbi.2010.12.015 Xanthos, 2014, Neurogenic neuroinflammation: Inflammatory CNS reactions in response to neuronal activity, Nat Rev Neurosci, 15, 43, 10.1038/nrn3617 Skaper, 2012, Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide, Philos Trans R Soc Lond B Biol Sci, 367, 3312, 10.1098/rstb.2011.0391 Skaper, 2012, Microglia and mast cells: Two tracks on the road to neuroinflammation, FASEB J, 26, 3103, 10.1096/fj.11-197194 Jacobs, 2012, Noninvasive molecular imaging of neuroinflammation, J Cereb Blood Flow Metab, 32, 1393, 10.1038/jcbfm.2012.53 Wilcox, 2014, Does brain inflammation mediate pathological outcomes in epilepsy?, Adv Exp Med Biol, 813, 169, 10.1007/978-94-017-8914-1_14 Skaper, 2014, Mast cells, glia and neuroinflammation: Partners in crime?, Immunology, 141, 314, 10.1111/imm.12170 Abbott, 2012, Overview and introduction: The blood-brain barrier in health and disease, Epilepsia, 53, 1, 10.1111/j.1528-1167.2012.03696.x Griffiths, 2009, The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain, J Neuropathol Exp Neurol, 68, 217, 10.1097/NEN.0b013e3181996688 Bailey, 2006, Innate and adaptive immune responses of the central nervous system, Crit Rev Immunol, 26, 149, 10.1615/CritRevImmunol.v26.i2.40 Hickey, 2001, Basic principles of immunological surveillance of the normal central nervous system, Glia, 36, 118, 10.1002/glia.1101 Aloisi, 2001, Immune function of microglia, Glia, 36, 165, 10.1002/glia.1106 Neumann, 2001, Control of glial immune function by neurons, Glia, 36, 191, 10.1002/glia.1108 Monier, 2007, Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex, J Neuropathol Exp Neurol, 66, 372, 10.1097/nen.0b013e3180517b46 Chinnery, 2010, Novel characterization of monocyte-derived cell populations in the meninges and choroid plexus and their rates of replenishment in bone marrow chimeric mice, J Neuropathol Exp Neurol, 69, 896, 10.1097/NEN.0b013e3181edbc1a Ziebell, 2014, Microglia: Dismantling and rebuilding circuits after acute neurological injury, Metab Brain Dis, 10.1007/s11011-014-9539-y Ferrini, 2013, Microglia control neuronal network excitability via BDNF signalling, Neural Plast, 429815, 2014 Ashhab, 2013, Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy, J Mol Neurosci, 51, 950, 10.1007/s12031-013-0013-9 Devinsky, 2013, Glia and epilepsy: Excitability and inflammation, Trends Neurosci, 36, 174, 10.1016/j.tins.2012.11.008 Farina, 2007, Astrocytes are active players in cerebral innate immunity, Trends Immunol, 28, 138, 10.1016/j.it.2007.01.005 Seifert, 2010, Astrocyte dysfunction in epilepsy, Brain Res Rev, 63, 212, 10.1016/j.brainresrev.2009.10.004 Sofroniew, 2010, Astrocytes: Biology and pathology, Acta Neuropathol, 119, 7, 10.1007/s00401-009-0619-8 Aronica, 2011, Inflammation in epilepsy: Clinical observations, Epilepsia, 52, 26, 10.1111/j.1528-1167.2011.03033.x Vezzani, 2008, The role of cytokines in the pathophysiology of epilepsy, Brain Behav Immun, 22, 797, 10.1016/j.bbi.2008.03.009 Maroso, 2011, Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: The importance of IL-1beta and high-mobility group box 1, J Intern Med, 270, 319, 10.1111/j.1365-2796.2011.02431.x O׳Neill, 2008, The interleukin-1 receptor/Toll-like receptor superfamily: 10 Years of progress, Immunol Rev, 226, 10, 10.1111/j.1600-065X.2008.00701.x Vezzani, 2011, Epilepsy and brain inflammation, Exp Neurol, 244, 11, 10.1016/j.expneurol.2011.09.033 Vezzani, 2011, The role of inflammation in epilepsy, Nat Rev Neurol, 7, 31, 10.1038/nrneurol.2010.178 Carare, 2014, Afferent and efferent immunological pathways of the brain. Anatomy, function and failure, Brain Behav Immun, 36, 9, 10.1016/j.bbi.2013.10.012 Weller, 2010, Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis, Pathophysiology, 17, 295, 10.1016/j.pathophys.2009.10.007 Greenwood, 2011, Review: Leucocyte-endothelial cell crosstalk at the blood-brain barrier: A prerequisite for successful immune cell entry to the brain, Neuropathol Appl Neurobiol, 37, 24, 10.1111/j.1365-2990.2010.01140.x Williams, 2001, Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system, Glia, 36, 156, 10.1002/glia.1105 Katsetos, 1999, Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children, Clin Diagn Lab Immunol, 6, 105, 10.1128/CDLI.6.1.105-114.1999 Owens, 2008, Perivascular spaces and the two steps to neuroinflammation, J Neuropathol Exp Neurol, 67, 1113, 10.1097/NEN.0b013e31818f9ca8 Arjmandi, 2009, Dendritic cell adhesion to cerebral endothelium: Role of endothelial cell adhesion molecules and their ligands, J Neuropathol Exp Neurol, 68, 300, 10.1097/NEN.0b013e31819a8dd1 Prinz, 2010, Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS, J Neuroimmunol, 224, 80, 10.1016/j.jneuroim.2010.05.015 Kopeloff, 1947, The experimental production of epilepsy in animals, Proc Annu Meet Am Psychopathol Assoc, 36, 163 Mihailovic, 1961, Effects of intraventricularly injected anti-n. caudatus antibody on the electrical activity of the cat brain, Nature, 192, 665, 10.1038/192665a0 Karpiak, 1973, Epileptiform activity induced by antiserum to synaptic membrane, Brain Res, 59, 303, 10.1016/0006-8993(73)90268-0 Karpiak, 1974, Immunologically induced behavioral and electrophysiological changes in the rat, Neuropsychologia, 12, 313, 10.1016/0028-3932(74)90046-3 Karpiak, 1976, Antiserum to brain gangliosides produces recurrent epileptiform activity, Science, 194, 735, 10.1126/science.982041 Karpiak, 1982, Immunological model of epilepsy. Epileptiform activity induced by fragments of antibody to GM1 ganglioside, J Neuroimmunol, 3, 15, 10.1016/0165-5728(82)90014-5 Frieder, 1982, Effect of antiepileptic drugs and an anticonvulsant on epileptiform activity induced by antibodies to ganglioside, Exp Neurol, 78, 644, 10.1016/0014-4886(82)90081-4 Frieder, 1981, Enhancement of depolarization-induced release of gamma-aminobutyric acid from brain slices by antibodies to ganglioside, J Neurochem, 37, 634, 10.1111/j.1471-4159.1982.tb12534.x Takigawa, 1995, Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers, Ann Neurol, 37, 436, 10.1002/ana.410370405 Harris, 1972, Degeneration in experimental epileptic foci, Arch Neurol, 26, 434, 10.1001/archneur.1972.00490110068007 Cazzullo, 1976, Cobalt-induced experimental epilepsy in cats pharmacologically immunodepressed. An EEG and histological study, Arzneimittelforschung, 26, 1387 Shaw, 1994, MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat, Neuropathol Appl Neurobiol, 20, 392, 10.1111/j.1365-2990.1994.tb00985.x Dambinova, 1998, Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy, J Neurochem, 71, 2088, 10.1046/j.1471-4159.1998.71052088.x Vezzani, 1999, Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures, J Neurosci, 19, 5054, 10.1523/JNEUROSCI.19-12-05054.1999 Donnelly, 1999, Glycerol-induced seizure: Involvement of IL-1beta and glutamate, Neuroreport, 10, 1821, 10.1097/00001756-199906230-00004 Jankowsky, 1999, Differential regulation of cytokine expression following pilocarpine-induced seizure, Exp Neurol, 159, 333, 10.1006/exnr.1999.7137 De Simoni, 2000, Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus, Eur J Neurosci, 12, 2623, 10.1046/j.1460-9568.2000.00140.x Vezzani, 2000, Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice, Proc Natl Acad Sci U S A, 97, 11534, 10.1073/pnas.190206797 Esen, 2001, Age dependent changes in some immune system parameters and GFAP immunoreactivity in genetically absence epileptic rats, Int J Neurosci, 109, 261, 10.3109/00207450108986537 Kubera, 2001, Immunoreactivity in kainate model of epilepsy, Pol J Pharmacol, 53, 541 During, 2000, An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy, Science, 287, 1453, 10.1126/science.287.5457.1453 Tuncok, 2001, Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion, Exp Clin Psychopharmacol, 9, 228, 10.1037/1064-1297.9.2.228 Voutsinos-Porche, 2004, Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy, Neurobiol Dis, 17, 385, 10.1016/j.nbd.2004.07.023 Omran, 2012, Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy, Epilepsia, 53, 1215, 10.1111/j.1528-1167.2012.03540.x Pernot, 2011, Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy, Epilepsia, 52, 2315, 10.1111/j.1528-1167.2011.03273.x Ravizza, 2011, Inflammation and prevention of epileptogenesis, Neurosci Lett, 497, 223, 10.1016/j.neulet.2011.02.040 Aronica, 2010, Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy, Eur J Neurosci, 31, 1100, 10.1111/j.1460-9568.2010.07122.x Musto, 2011, Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy, Epilepsia, 52, 551, 10.1111/j.1528-1167.2010.02920.x Xu, 2012, Altered expression of CX3CL1 in patients with epilepsy and in a rat model, Am J Pathol, 180, 1950, 10.1016/j.ajpath.2012.01.024 Peng, 2013, Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy, J Mol Neurosci, 50, 291, 10.1007/s12031-013-9953-3 Zhu, 2013, Progranulin promotes activation of microglia/macrophage after pilocarpine-induced status epilepticus, Brain Res, 1530, 54, 10.1016/j.brainres.2013.07.023 Maroso, 2010, Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures, Nat Med, 16, 413, 10.1038/nm.2127 Iori, 2013, Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures, Neurobiol Dis, 58, 102, 10.1016/j.nbd.2013.03.006 Gnatek, 2012, Acetylcholinesterase loosens the brain׳s cholinergic anti-inflammatory response and promotes epileptogenesis, Front Mol Neurosci, 5, 66, 10.3389/fnmol.2012.00066 Ndode-Ekane, 2013, Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy, Mol Neurobiol, 47, 914, 10.1007/s12035-012-8386-2 Nunan, 2014, Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release, Glia, 62, 1313, 10.1002/glia.22682 Ganor, 2014, Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior, Psychoneuroendocrinology, 42, 106, 10.1016/j.psyneuen.2014.01.005 Nitsch, 1983, Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents, J Neurol Sci, 59, 305, 10.1016/0022-510X(83)90016-3 Frigerio, 2012, Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology, Epilepsia, 53, 1887, 10.1111/j.1528-1167.2012.03666.x Marchi, 2010, Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity, Brain Res, 1353, 176, 10.1016/j.brainres.2010.06.051 Janigro, 2012, Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier, Epilepsia, 53, 26, 10.1111/j.1528-1167.2012.03472.x Suidan, 2010, CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions, J Immunol, 184, 1031, 10.4049/jimmunol.0902773 Marchi, 2009, Antagonism of peripheral inflammation reduces the severity of status epilepticus, Neurobiol Dis, 33, 171, 10.1016/j.nbd.2008.10.002 Fabene, 2013, Leukocyte trafficking mechanisms in epilepsy, Mol Immunol, 55, 100, 10.1016/j.molimm.2012.12.009 Rossi, 2011, Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions, J Leukoc Biol, 89, 539, 10.1189/jlb.0710432 Racusen, 1990, Cyclosporine lowers seizure threshold in an experimental model of electroshock-induced seizures in Munich-Wistar rats, Life Sci, 46, 1021, 10.1016/0024-3205(90)90026-N Silverberg, 2010, Lymphocyte infiltration of neocortex and hippocampus after a single brief seizure in mice, Brain Behav Immun, 24, 263, 10.1016/j.bbi.2009.10.006 Vezzani, 2014, Epilepsy and inflammation in the brain: Overview and pathophysiology, Epilepsy Curr, 14, 3, 10.5698/1535-7511-14.s2.3 Vezzani, 2013, The role of inflammation in epileptogenesis, Neuropharmacology, 69, 16, 10.1016/j.neuropharm.2012.04.004 Vezzani, 2013, Epilepsy and brain inflammation, Exp Neurol, 244, 11, 10.1016/j.expneurol.2011.09.033